These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 9110065)

  • 21. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cidofovir: new preparation. Of help in CMV retinitis.
    Prescrire Int; 1998 Oct; 7(37):135-7. PubMed ID: 10915415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
    Lalezari JP; Friedberg DN; Bissett J; Giordano MF; Hardy WD; Drew WL; Hubbard LD; Buhles WC; Stempien MJ; Georgiou P; Jung DT; Robinson CA;
    J Clin Virol; 2002 Feb; 24(1-2):67-77. PubMed ID: 11744430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
    Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current strategies for treatment of CMV retinitis in patients with AIDS].
    Lüke C; Bartz-Schmidt KU; Walter P; Heimann K
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):4-9. PubMed ID: 10448631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
    Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
    Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of ganciclovir in the human retina.
    Park SS; Girard B; Font RL; Hauw JJ; Young LH
    Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
    Jacobson MA
    Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental cost-effectiveness analysis of intravenous ganciclovir versus oral ganciclovir in the maintenance treatment of newly diagnosed cytomegalovirus retinitis in patients with AIDS.
    Rachlis A; Smaill F; Walker V; Hotchkies L; Jones A
    Pharmacoeconomics; 1999 Jul; 16(1):71-84. PubMed ID: 10539123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
    Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
    Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose intravitreal ganciclovir in CMV retinitis].
    Cochereau I; Diraison MC; Mousalatti H; Bouyer I; Ren L; Guvenisik N; Hoang-Xuan T
    J Fr Ophtalmol; 2000 Feb; 23(2):123-6. PubMed ID: 10705113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M; Dunn JP
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMV treatment.
    Treat Rev; 1995; (no 19):4. PubMed ID: 11362756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis).
    Woodward J
    STEP Perspect; 1995; 7(2):2-4. PubMed ID: 11362720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patients.
    Owens RC; Ross JW
    Conn Med; 1996 Nov; 60(11):663-5. PubMed ID: 8979433
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.